Client News
Filter by:
- Sep 13 2021 AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
- Sep 10 2021 AzurRx BioPharma Announces Reverse Stock Split
- Sep 10 2021 AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
- Aug 16 2021 OncoSec Provides Leadership Update
- Jul 26 2021 OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
- Jan 26 2021 BG Staffing, Inc. Announces Corporate Name Change to BGSF, Inc. to Reflect Broader Workforce Solutions Strategy
- Dec 10 2020 VistaGen Announces Korean Intellectual Property Office Decision to Grant PH10 Patent for Treatment of Depression
- Dec 1 2020 VistaGen Therapeutics Expands R&D Team with Appointment of Louis Monti, M.D., Ph.D., Pioneer in the Development of Neuroactive Steroids known as Pherines as Potential Treatments for Anxiety and Depression Disorders, as Vice President, Translational Medicine
- Dec 1 2020 Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- Dec 1 2020 Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update